Letter: Clonazepam in the treatment of drug-induced dyskinesia. 1975

P M O'Flanagan

UI MeSH Term Description Entries
D009069 Movement Disorders Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions. Dyskinesia Syndromes,Etat Marbre,Status Marmoratus,Movement Disorder Syndromes,Dyskinesia Syndrome,Movement Disorder,Movement Disorder Syndrome
D009574 Nitro Compounds Compounds having the nitro group, -NO2, attached to carbon. When attached to nitrogen they are nitramines and attached to oxygen they are NITRATES. Nitrated Compounds
D002722 Chlorobenzenes Aromatic organic compounds with the chemical formula C6H5Cln.
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001570 Benzodiazepinones

Related Publications

P M O'Flanagan
September 1976, British medical journal,
P M O'Flanagan
January 1984, Revista de medicina interna, neurologie, psihiatrie, neurochirurgie, dermato-venerologie. Neurologie, psihiatrie, neurochirurgie,
P M O'Flanagan
August 1981, The American journal of psychiatry,
P M O'Flanagan
April 1990, The American journal of psychiatry,
P M O'Flanagan
May 2024, Clinical case reports,
P M O'Flanagan
November 1975, British medical journal,
P M O'Flanagan
February 1981, The American journal of psychiatry,
P M O'Flanagan
October 1974, La Nouvelle presse medicale,
Copied contents to your clipboard!